Novozymes | NZYMB - Ebitda

Aktienkurs
378.20
Täglich Wechseln
1.20 0.32%
Monatlich
-1.61%
Jährlich
-2.35%
Q2 Prognose
360.48




Ebitda Veränderung Datum
Arq USD 265K 4.9M 2025-12
Avient USD 149.9M 31.8M 2026-03
Chemours USD 169M 87M 2026-03
Coronado Global Resources USD -56.02M 33.48M 2025-12
Corteva USD 1.44B 992M 2026-03
Metallus USD 2.4M 26.6M 2025-12
Newmont Corporation USD 3.31B 494M 2025-09
Novozymes 364.6M 30.7M 2025-12
SSR Mining USD 340.57M 99.57M 2026-03